G-CSF zur Prophylaxe der Neutropenie und der febrilen Neutropenie, Anämie bei Krebserkrankung-Reference-Cited by-同舟云学术

G-CSF zur Prophylaxe der Neutropenie und der febrilen Neutropenie, Anämie bei Krebserkrankung

Published:2022-06 Issue:6 Volume:17 Page:298-314
ISSN:0946-4565
Container-title:best practice onkologie
language:de
Short-container-title:best practice onkologie

Author:

Link Hartmut

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

https://link.springer.com/content/pdf/10.1007/s11654-022-00398-0.pdf

Reference106 articles.

1. Gabrilove JL, Jakubowski A, Scher H, Sternberg C, Wong G, Grous J et al (1988) Effect of granulocyte colony-stimulating factor on neutropenia and associated morbidity due to chemotherapy for transitional-cell carcinoma of the urothelium. N Engl J Med 318:1414–1422

2. (2017) CTEP: common terminology criteria for adverse events (CTCAE) v5.0., https://ctep.cancer.gov/protocoldevelopment/electronic_applications/docs/CTCAE_v5_Quick_Reference_5x7.pdf. Zugegriffen: 26.04.2022

3. Heinz WJ, Buchheidt D, Christopeit M, von Lilienfeld-Toal M, Cornely OA, Einsele H et al (2017) Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO). Ann Hematol 96(11):1775–1792. https://doi.org/10.1007/s00277-017-3098-3

4. Sternberg CN, Mulder PH, Schornagel JH, Théodore C, Fossa SD, Oosterom ATv et al (2001) Randomized phase III trial of high–dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European organization for research and treatment of cancer protocol no. 30924. J Clin Oncol 19(10):2638–2646. https://doi.org/10.1200/jco.2001.19.10.2638

5. Sternberg CN, de Mulder P, Schornagel JH, Theodore C, Fossa SD, van Oosterom AT et al (2006) Seven year update of an EORTC phase III trial of high-dose intensity M‑VAC chemotherapy and G‑CSF versus classic M‑VAC in advanced urothelial tract tumours. Eur J Cancer 42(1):50–54. https://doi.org/10.1016/j.ejca.2005.08.032

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kombination Radio(chemo)therapie beim Lungenkarzinom – Nebenwirkungsmanagement;best practice onkologie;2023-10-10